EssilorLuxottica: Is the distribution phase coming to an end ?
| Entry price | Target | Stop-loss | Potential |
|---|
|
€172.65 |
€190 |
€163 |
+10.05% |
|---|
After several weeks of range-bound movement, shares in EssilorLuxottica could enter into a new clear trend. The exit out of the current trading range could be the signal for a return of volatility.
Summary● The company's MSCI ESG score, based on a ranking of the company relative to its industry, comes out particularly well.
● Over the past year, analysts have regularly revised upwards their sales forecast for the company.
● Analysts covering this company mostly recommend stock overweighting or purchase.
● The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
● Over the past twelve months, analysts' opinions have been strongly revised upwards.
● The company benefits from high valuations in earnings multiples.
● For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
● The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
● The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.
● The company's earnings releases usually do not meet expectations.
© MarketScreener.com -
2026
The content herein constitutes a general investment recommendation, prepared in accordance with provisions aimed at preventing market abuse by Surperformance, the publisher of MarketScreener UK. More specifically, this recommendation is based on factual elements and expresses a sincere, complete, and balanced opinion. It relies on internal or external data, considered reliable as of the date of their release. Nevertheless, this information, and the resulting recommendation, may contain inaccuracies, errors, or omissions, for which Surperformance cannot be held responsible. This recommendation, which in no way constitutes investment advice, may not be suitable for all investor profiles. The reader acknowledges and accepts that any investment in a financial instrument involves risks, for which they assume full responsibility, without recourse against Surperformance. Surperformance commits to disclosing any conflict of interest that may affect the objectivity of its recommendations.
